Published Online
on July 27, 2009

A more recent version of this article appeared on August 11, 2009

This Article Full Text (PDF) All Versions of this Article: 120/6/464    most recent CIRCULATIONAHA.109.883629v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Braverman, A. C. PubMed PubMed Citation Articles by Braverman, A. C. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Marfan Syndrome Related Collections ACE/Angiotension receptors Animal models of human disease Genetically altered mice Genetics of cardiovascular disease Other Vascular biology Related Article

Submitted on ,
Accepted on ,

Transforming Growth Factor-. A Biomarker in Marfan Syndrome?

Alan C. Braverman MD^*

From the Department of Medicine, Cardiovascular Division, Washington University School of Medicine, St Louis, Mo.

^* To whom correspondence should be addressed. E-mail: abraverm{at}dom.wustl.edu.

Key words: Editorials • aneurysm • angiotensin • aorta • genetics • Marfan syndrome

Related Article:

Circulating Transforming Growth Factor-β in Marfan Syndrome

Peter Matt, Florian Schoenhoff, Jennifer Habashi, Tammy Holm, Christel Van Erp, David Loch, Olga D. Carlson, Benjamin F. Griswold, Qin Fu, Julie De Backer, Bart Loeys, David L. Huso, Nazli B. McDonnell, Jennifer E. Van Eyk, Harry C. Dietz, and the GenTAC Consortium
Circulation 2009 120: 526-532. [Abstract] [Full Text]

This article has been cited by other articles:

				Briefly Noted Journal Watch Dermatology, October 30, 2009; 2009(1030): 1 - 1. [Full Text]